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NANOTECHNOLOGY PATENT LAW: A CASE STUDY OF
UNITED STATES AND EUROPEAN PATENT
APPLICATIONS
By Michael Costello-Caulkins1
As nanotechnology moves from research development to
commercial development, applicants are seeking patents outside the
United States and in European markets in greater numbers. As a
consequence, understanding the challenges of international
prosecution is of growing importance to nanotechnology companies.
One way to understand these challenges is to look at how jurisdictions
are treating patents. This article focuses on four case studies of
nanotechnology patent applications filed in the United States and
Europe. Ultimately, the European applications were abandoned
earlier in prosecution and in greater numbers than the US applications
and, where patents issued in both jurisdictions, the European patents
contained narrower claims. This is attributable to different prior art
relied on by the European Patent Office, which read on more claims
and required additional claim limitations than the US prior art. To
provide context to the case study a definition of nanotechnology, a
comparison of the patent laws, and a summary of previous scholarship
are also discussed.

1
JD Candidate, Santa Clara University School of Law, 2021. The author
thanks Colleen V. Chien, Professor of Law at Santa Clara University School
of Law, and the editors of the Santa Clara High Technology Law Journal for
their helpful edits.
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INTRODUCTION
Nanotechnology has become increasingly relevant across a wide
range of fields.2 For example, nanotechnology is critical to the mRNA
COVID-19 vaccine developed by Moderna, Inc.3 The mRNA
technology “employs nanoparticles-based drug release approaches”4
that allow for improved penetration into tissues and low toxicity to the
body.5 Additionally, major manufacturing hurdles have been overcome
in the creation of a 16-bit microprocessor comprising carbon nanotube
transistors which are ten times as energy efficient as silicon transistors.6
It is safe to say that nanotechnology is a rapidly growing technological
area. As a result, there are a growing number of patent applications
being filed.7
In 2020, about three percent of the total patent applications filed at
the United States Patent and Trademark Office (“USPTO”) and the
European Patent Office (“EPO”) were related to nanotechnology.8 In
terms of granted patents and published patent applications, a total of
22,462 and 5,292 nanotechnology patents were issued by the USPTO
and EPO respectively.9 The EPO’s nanotechnology patents account for
23.6% of the USPTO’s patents, showing a sizable increase compared
to 2016 (i.e., 18%).10 This growth reveals “the considerable attention
of countries and companies all over the world to the EU’s
nanotechnology markets compared to the US ones.”11

2

Benefits and Applications, NANO.GOV: NATIONAL NANOTECHNOLOGY
INITIATIVE, https://www.nano.gov/you/nanotechnology-benefits.
3
Technology Against COVID-19: Nano Insights into Prevention, Diagnosis,
and Treatment, STATNANO, https://statnano.com/technology-against-covid19-nano-insights.
4
Id.
5
Lipid Nanoparticles, PRECISION NANOSYSTEMS,
https://www.precisionnanosystems.com/workflows/formulations/lipidnanoparticles.
6
Becky Ham, Carbon nanotube transistors make the leap from lab to factory
floor, MIT NEWS: ON CAMPUS AND AROUND THE WORLD (June 1, 2020),
https://news.mit.edu/2020/carbon-nanotube-transistors-factory-0601.
7
A Statistical Look at USPTO Nanotechnology Patents Published in 2020,
STATNANO (Jan. 26, 2021), https://statnano.com/news/68609/A-StatisticalLook-at-USPTO-Nanotechnology-Patents-Published-in-2020.
8
Id.
9
2020’s Statistical Review of Top Countries in Holding Nanotechnology
Patents, STATNANO (Feb. 1, 2021), https://statnano.com/news/68635/2020’sStatistical-Review-of-Top-Countries-in-Holding-Nanotechnology-Patents.
10
Id.
11
Id.
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As the EU’s nanotechnology market continues to grow, it is
important for US companies considering patent protection in Europe to
understand the challenges of pursuing an international patent portfolio.
To highlight how European patent law differs from United States law
in regard to nanotechnology, this paper presents four case studies of
nanotechnology patent applications. More specifically, I identify four
pairs of “matched USPTO-EPO patent application twins”12 and analyze
their prosecution histories. Each of the pairs refers to early
nanotechnology patents that sought to protect the basic ideas of the
technology,13 which highlight some of the issues unique to the field. To
the same end, this article presents a definition of nanotechnology, a
comparison of US and European patent law, and a summary of the
relevant scholarship.
Based on the EPO’s greater understanding of the issues affecting
nanotechnology patents and better reputation, I hypothesize that the
European patent applications will issue into patents at a lower rate than
the US applications and contain narrower claims. The results of the four
case studies largely confirm my hypothesis. I find that it is much harder
to get a nanotechnology patent in Europe than it is in the US, in part,
because the EPO relies on better prior art than the USPTO.
I.

DEFINING NANOTECHNOLOGY

Nanotechnology involves science at the nanometer scale.14 A
nanometer is a unit of measure that is one billionth of a meter and
materials at this size have unique properties that are governed less by
the traditional laws of physics and more by the behavior of individual
atoms and molecules.15 This can be quite different than the behavior
exhibited by the same material in bulk. For instance, aluminum in bulk
is stable but at the nanoscale it is combustible.16 Gold also undergoes a

12

Colleen Chien, Comparative Patent Quality, 50 ARIZ. ST. L.J. 71, 102
(2018).
13
See discussion infra Section IV.
14
What It Is and How It Works, NANO.GOV: NATIONAL NANOTECHNOLOGY
INITIATIVE, https://www.nano.gov/nanotech-101/what.
15
Mark A. Lemley, Patenting Nanotechnology, 58 STAN. L. REV. 601, 602
(2005) (discussing how the characteristics of nanoscale materials lie “between
the classical large-molecule level to which traditional physics and chemistry
apply and the atomic level in which the bizarre rules of quantum mechanics
take effect”); Ten Things You Should Know About Nanotechnology,
NANOWERK,
https://www.nanowerk.com/nanotechnology/ten_things_you_should_know_
3.php [hereinafter Ten Things].
16
Ten Things, supra note 15.
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transformation as it gets smaller and smaller, eventually turning to
liquid at room temperature.17
Patent offices have defined nanotechnology accordingly. Both
the USPTO and EPO have designated nanotechnology with its own
class designation: class 977 and B82Y, respectively.18 With regard to
size, the USPTO defines a nanostructure as having at least one physical
dimension of approximately 1-100 nanometers.19 Similarly, the EPO
states that a nanostructure must have “at least one nanosized functional
component,” where “nanosized” relates to a dimension below 100
nanometers.20 With regard to properties, both offices state in similar
terms that the nanostructure must have a special property that is
uniquely attributable to the nanoscale.21
II.

UNITED STATES & EUROPEAN PATENT SYSTEMS

Before looking at the data, it is important to understand the
patent system in each region. Specifically, it is important to understand
the difference in legal standards and evidentiary processes, with a focus
on which regime encourages a more rigorous examination. This paper
touches on provisions that were particularly relevant in the prosecution
of these patents: novelty and non-obviousness. It is worth noting the
patents in this paper were all filed before March 16, 2013, so the preAIA provisions of the US Code are applicable.
A. Novelty
With regard to novelty, 35 US Code Section 102 governs, and
section (a) says that an invention is not novel if it is known or used in
the US, or if it is published anywhere in the US or a foreign country.22
Case law has defined a published reference as one that has been
disseminated or made available so persons interested and ordinarily
skilled in the subject matter can locate it.23 Case law has also defined
17

Id.
Class 977 Nanotechnology, USPTO,
https://www.uspto.gov/web/patents/classification/uspc977/defs977.htm
[hereinafter USPTO]; Nanotechnology, EUROPEAN PATENT OFFICE: NEWS &
EVENTS, https://www.epo.org/news-events/infocus/classification/nanotechnology.html.
19
USPTO, supra note 18.
20
COOPERATIVE PATENT CLASSIFICATION, DEFINITION: B82Y (2017).
21
Id.; USPTO, supra note 18.
22
Melanie J. Howlett & Andrew F. Christie, An Analysis of the Approach of
the European, Japanese and United States Patent Office to Patenting Partial
DNA Sequences (ESTS), 34 INT’L REV. INDUS. PROP. & COPYRIGHT 581, 591
(2003).
23
Id.
18
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“known or used” as that which is accessible to the public, with no
deliberate attempt to keep it secret.24
In Europe, novelty is governed by Article 54 of the European
Patent Convention (“EPC”).25 Article 54 mandates that “an invention
shall be considered to be new if it does not form part of the state of the
art.”26 The state of the art comprises “everything made available to the
public by means of a written or oral description, by use or in any other
way, before the date of the filing of the European patent application.”27
Lack of novelty can be evident from explicit statements in the
document, or it can be implicit, “such that a skilled person would
inevitably arrive at the claimed invention by following the teaching of
the prior document.”28
In practice, there are two key differences between the novelty
requirements. First, Europe follows the principle of absolute novelty,
meaning a patent application must be filed before the occurrence of any
activity that would constitute prior art.29 In the US, there is a one-year
grace period from initial public disclosure or commercial use in which
an inventor can file a patent application and still obtain a valid patent.30
Second, Europe follows a policy of qualified public use, where the
public disclosure actually has to enable someone to figure out what the
invention is.31 In the US, neither public disclosure nor commercial use
has to be enabling.32
B. Non-obviousness
In the US, non-obviousness is covered in 35 US Code Section
103.33 Section 103 states that a patent will be rejected when the
collective prior art suggests to a person skilled in the art that the
patent’s claim was obvious.34 Non-obviousness analysis is fact
dependent and requires comparing the claimed subject matter as a
24

Id.
European Patent Convention art. 54, Oct. 5, 1973, 1065 U.N.T.S. 272.
26
Id.
27
Id.
28
Howlett & Christie, supra note 22, at 588.
29
Jeffrey M. Kaden, Patent Protection and the Novelty Requirement,
GOTTLIEB, RACKMAN & REISMAN, P.C., https://grr.com/publications/patentprotection-novelty-requirement/.
30
Id.
31
Andre Marais, Schwegman Lundberg & Woessner, US vs EP Patent
Consideration: A Practical Guide to the Differences, Presentation at Santa
Clara School of Law (Oct. 6, 2020).
32
Id.
33
35 U.S.C. § 102 (2015).
34
Id.
25
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whole to the prior art.35 To establish a prima facie case of obviousness
an examiner can show three things: (1) a suggestion or motivation in
the prior art to modify the reference; (2) a reasonable expectation of
success in combining or modifying the prior art to arrive at the claimed
invention; and (3) prior art references that suggest all of the claim
limitations.36 Importantly, obviousness is judged by the hypothetical
person of ordinary skill right before the invention was made.37
Under the EPC, Article 56 states that an invention has an
inventive step, if “having regard to the state of the art, it is not obvious
to a person skilled in the art.”38 This is evaluated using a “problemsolution” approach which involves three steps: (1) determining the
closest prior art; (2) establishing the technical problem to be solved in
the present application; and (3) considering whether the present
invention, beginning with the closest prior art and the technical
problem, would have been obvious to a person skilled in the art.39
Obvious is defined as “not going beyond the normal progress of
technology but rather following plainly or logically from that prior
art.”40 Importantly, the closest prior art must be in the same technical
field and must address the same problem as the present invention.41
In practice, the European “problem-solution” approach
requires an examiner to strike out all non-technical language in the
claims and any claim element that appears in the prior art.42 If what
remains is a technical solution to a technical problem, an inventive step
exists.43 This inquiry resembles an eligible subject matter evaluation
and is quite different than the US approach, which focuses primarily
on whether the combination of prior art is obvious and contains every
claim element.44

35

Howlett & Christie, supra note 22, at 592.
Id.
37
Id.; Tom Irving, Obviousness: Overcoming Obviousness Rejections by
Attacking the Prima Facie Case, LEXIS PRACTICE ADVISOR 2,
https://www.finnegan.com/images/content/2/5/v2/255327/PUBLISHEDLexis-Practice-Advisor-Obviousness-Overcoming-Obvi.pdf.
38
European Patent Convention art. 56, Oct. 5, 1973, 1065 U.N.T.S. 273.
39
Howlett & Christie, supra note 22, at 589.
40
Id. at 590.
41
Id. at 589–90.
42
Andre Marais, Schwegman Lundberg & Woessner, US vs EP Patent
Consideration: A Practical Guide to the Differences, Presentation at Santa
Clara University School of Law (Oct. 6, 2020).
43
Id.
44
Id.
36
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RELEVANT SCHOLARSHIP

There are a couple areas of patent scholarship that are
applicable to this case study. The first has to do with patenting
nanotechnology and the second, more generally, compares obtaining
patent rights in the US and Europe. Scholarship on patenting
nanotechnology tends to be region specific, with the exception of a
single case study that compared the prosecution of a nanotechnology
patent application in the US and Europe.45 This section briefly
summarizes the prior art and provides a prediction about the results of
this case study.
The first area of relevant patent scholarship looks at
nanotechnology patents. Most authors focus on subject matter of early
nano patents, the cross disciplinary nature of nano patents,46 and
novelty concerns with miniaturizing prior inventions.47 In both the US
and Europe, the basic ideas, or “building blocks,” of nanotechnology
were patented.48 For example, in the US, patents have issued on carbon
nanotubes, semiconducting and light emitting nanocrystals, nanorods,
and methods for making nanotubes and nanocrystals.49 This is the first
area of technology in almost one hundred years in which the building
45

Luca Escoffier, Nanotechnology Under the Magnifying Lens from a
European and U.S. Perspective: General Patent Statistics, Non-Obviousness
Versus Inventive Step, and Two Case Studies in CNT Commercialization
(Stanford – Vienna Transatlantic Technology Law Forum Working Paper
Series,
Paper
No.
3,
2009),
https://law.stanford.edu/wpcontent/uploads/sites/default/files/publication/205107/doc/slspublic/escoffier
_wp3.pdf.
46
For scholarship on the subject matter and cross disciplinary nature of nano
patents see Lemley, supra note 15, at 606–14; Amit Makker, The
Nanotechnology Patent Thicket and the Path to Commercialization, 84 S.
CAL. L. REV. 1163 (2011); Maurice H.M. Schellekens, Patenting
Nanotechnology in Europe: Making a Good Start? An Analysis of Issues in
Law and Regulation, 9 (TILT Law & Tech., Working Paper No. 008/2008,
2008), https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1139080.
47
See Emily M. Morris, The Irrelevance of Nanotechnology Patents, 49 CONN.
L. REV. 499 (Dec. 2016); Jordan Paradise, Claiming Nanotechnology:
Improving USPTO Efforts at Classification of Emerging Nano-Enabled
Pharmaceutical Technologies, 10 NW. J. TECH. & INTELL. PROP. 169, 175
(2012); Andrew Wasson, Protecting the Next Small Thing: Nanotechnology
and the Reverse Doctrine of Equivalent, 2004 DUKE L. & TECH. REV. 10
(2004); Christopher Anderson, Small Can be Inventive: The Patentability of
Nanoscale Reproductions of Macroscale Machines, 9 Wm. & Mary Bus. L.
Rev. 295 (Nov. 2017).
48
Lemley, supra note 15, at 606–14.
49
Id.
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blocks were patented from the beginning.50 In fields like computer
hardware, the internet, and biotechnology, early research was
conducted by the US government or the US government compelled
companies and universities to license their patents.51 Nanotechnology
has not been subject to the same government-mandated licenses or
policies against university patenting and, as a result, patenting occurred
early.52 The European Commission has expressed concern that
“nanotechnology is raising fundamental questions as to what should,
and should not be patentable, e.g., on the level of individual
molecules.”53 Additionally, the EPO has worked on instruments to
monitor nanotechnology patents to prevent over patenting.54
Scholarship also focuses on the cross-disciplinary structure of
nanotechnology.55 Particularly, patents on the basic ideas can affect
multiple fields ranging from biomedicine to telecommunications.56
Patentees will consequently have rights in several industries, and
expertise in each industry will be required to commercialize each
patent.57 This has raised practical concerns in Europe such as what
disciplines should the person skilled in the art have.58 One commentator
has suggested defining a person skilled in the art as a team of people,
each skilled in a discipline that could be used by the invention.59
Nanotechnology patents also raise the unique issue whether
macroscale devices can be prior art for nanoscale inventions. When
considered broadly, courts have found that a patent covers the same
invention independent of its size.60 But nanotechnology is
fundamentally different in that its material properties are not present at
the macroscale.61 One case in particular has dealt with issues regarding
the size range of nanotechnology, finding that a nanotechnology patent
can infringe a non-nanotechnology patent where the two patents

50

Id.
Id.
52
Id.
53
Schellekens, supra note 46.
54
Id. at 7.
55
See Lemley, supra note 15, at 614; Makker, supra note 46; Schellekens,
supra note 46.
56
Lemley, supra note 15.
57
Makker, supra note 46, at 1173.
58
Schellekens, supra note 46.
59
Id.
60
Anderson, supra note 47, at 287.
61
Id.
51
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specify particles with overlapping size ranges.62 In contrast, when
faced with situations where a nano-patent overlaps with ranges
mentioned in the prior art, the EPO’s Technical Board of Appeal has
noted that the prior art was not novelty destroying because the prior art
did not provide specific examples in the overlapping part of the range.63
One case study has compared the prosecution of a
nanotechnology patent in the US and Europe.64 The patent pertained to
patterning carbon nanotubes and was subject to two office actions in
the US where the examiner had the applicant restrict the patent to one
of two enclosed inventions and make minor formal amendments to the
application.65 The applicant submitted a supplemental European search
report to the examiner, which was acknowledged, but had no effect on
the outcome of the application.66 The application eventually issued as
a patent.67 In Europe, the application was found to lack novelty and
inventive step based on two patents that were cited references in the
US patent.68 The applicants slightly amended the claims but after the
EPO considered a new, non-patent reference relevant, that was cited in
the supplemental European search report, the application was
abandoned.69 The author concluded the case study “exemplifies how
cumbersome an international prosecution can be.”70
More generally, the EPO has long held a reputation as the
“gold standard” among patent offices in terms of patent quality.71 This
is because the EPO makes upfront investment in prosecution, regularly
relies on non-patent references, and caps application continuations
following rejections.72 By contrast, the USPTO is not held in as high
regard in terms of patent quality, in part, because their continuation
policy allows applicants to continue prosecuting applications despite
final rejection.73 The USPTO also falls behind the EPO in several key
metrics. For example, the EPO spends thirty hours examining a patent

62

Paradise, supra note 47 (discussing Elan Pharma Int’l Ltd. v. Abraxis
Bioscience Inc., No. 06-438 GMS, 2007 WL 6382930 (D. Del. Dec. 17,
2007)).
63
Schellekens, supra note 46.
64
Escoffier, supra note 45.
65
Id. at 28.
66
Id. at 29.
67
Id.
68
Id.
69
Id. at 30.
70
Escoffier, supra note 45, at 30.
71
Chien, supra note 12, at 74.
72
Id. at 101–20.
73
Id. at 106.
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compared to the USPTO’s thirteen hours.74 Additionally, the EPO
typically applies a team of three examiners to a patent, whereas the
USPTO applies one primary examiner.75 In sum, the EPO invests
heavily in getting patent quality right at early stages of prosecution,
which, not surprisingly, leads to higher rates of abandonment when
compared to the USPTO.76
For several reasons, the US patent applications in this case
study should issue into patents at a higher rate than the European
applications, and in cases where applications issue in both jurisdictions,
contain broader claims. The EPO not only appears to have a greater
understanding of the unique issues affecting nanotechnology patents,77
but their reputation as a better patent office78 would make it more
difficult for applicants to obtain a patent. Additionally, the previous
nano patent case study suggests that nano patents are more difficult to
obtain in Europe than in the US.79
IV.

THE CASE STUDY

Comparative studies of patent law are not new. Many studies
have been done comparing the law between regions,80 but few studies
have been conducted at the case study level. In addition,
nanotechnology has been studied for a long time,81 but the study of
nanotechnology patents is less prevalent. To understand the differences
in patent law between the US and Europe with respect to
nanotechnology, this section analyzes four pairs of nanotechnology
patent applications. I initially searched for “building-block” patents

74

Id. at 111.
Id.
76
Id. at 107.
77
Schellekens, supra note 46, at 7, 9.
78
Chien, supra note 12, at 74.
79
Escoffier, supra note 45, at 30.
80
Chien, supra note 12; Paul H. Jensen et al., Disharmony in International
Patent Office Decisions, 15 FED. CIR.B.J. 679, 679–82 (2006); Alfons
Palangkaraya et al., Misclassification Between Patent Offices: Evidence from
a Matched Sample of Patent Applications, 93 REV. ECON. & STAT. 1063,
1063–64 (2011); Elizabeth Webster et al., Characteristics of International
Patent Application Outcomes, 95 ECON. LETTERS 362, 367–68 (2007).
81
See Samer Bayda et al., The History of Nanoscience and Nanotechnology:
From Chemical-Physical Applications to Nanomedicine, MOLECULES (Dec.
27, 2019), https://www.mdpi.com/1420-3049/25/1/112 (Richard Feynman
introduced the concept of nanotechnology in 1959 during the annual meeting
of the American Physical Society).
75
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and found ten,82 however, only three had European counterparts and,
of those three, only two had US file wrappers that were published
online.83 To find a larger sample of accessible EPO/USPTO patent
applications, I searched for similar applications using Google Patents
and identified nine matched pairs of EPO/USPTO patent
applications.84 Notably, five of these pairs contained abandoned
European patent applications,85 and one contained an abandoned US
application.86 For this study, I selected one of the pairs containing an
abandoned European application,87 the one pair containing an
abandoned US application,88 and one pair where both the US and
European applications issued into patents.89 In summary, these
applications cover fundamental nanotechnology inventions chosen for
their significance in the field, in addition to the fact that patent
protection was sought both in the US and Europe.
A. Case 1: US 7,425,368 & WO 2006/023697
US patent 7,425,368 started as a provisional application filed
on August 20, 2004.90 The invention contained 19 claims and described
a polymer infused with nano particles which created a fiber with
82

Lemley, supra note 15, at 613–14 (citing ten patents on the basic ideas in
nanotechnology like carbon nanotubes, semiconducting nanocrystals, and
metal oxide nanorods).
83
Patent applications filed before June 20, 2003, were not scanned into the
Image File Wrapper system and so were not available online in public PAIR
after they published. MPEP § 1730 (II)(B)(1)(d) (8th ed. Rev. 7, Sept. 2008).
84
The nine US patent applications identified using Google Patents include
U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005); U.S.
Patent Application Serial No. 10/470,517 (filed July 29, 2003); U.S. Patent
Application Serial No. 10/090,223 (filed Mar. 4, 2002); U.S. Patent
Application Serial No. 10/549,950 (filed Mar. 19, 2004); U.S. Patent
Application Serial No. 10/976,179 (filed Oct. 29, 2004); U.S. Patent
Application Serial No.10/977,363 (filed Oct. 29, 2004); U.S. Patent
Application Serial No. 11/120,729 (file May 3, 2005); U.S. Patent Application
Serial No. 13/392,124 (filed Aug. 25, 2010); U.S. Patent Application Serial
No. 09/133.948 (filed Aug. 14, 1998).
85
U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005); U.S.
Patent Application Serial No. 10/470,517 (filed July 29, 2003); U.S. Patent
Application Serial No. 10/549,950 (filed Mar. 19, 2004); U.S. Patent
Application Serial No. 11/120,729 (file May 3, 2005); U.S. Patent Application
Serial No. 09/133.948 (filed Aug. 14, 1998).
86
U.S. Patent Application Serial No. 13/392,124 (filed Aug. 25, 2010).
87
U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005).
88
U.S. Patent Application Serial No. 13/392,124 (filed Aug. 25, 2010).
89
U.S. Patent Application Serial No.10/977,363 (filed Oct. 29, 2004).
90
U.S. Patent No. 7,425,368 at [22].
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improved axial strength.91 On December 14, 2007, the USPTO required
the patent to be restricted to one of the two inventions enclosed.92
Specifically, claims 1-14 of the application were drawn to the fiber,
while claims 15-19 were drawn to a method for making the fiber.93 On
January 18, 2008, the applicants replied electing to restrict the
invention to the claims drawn to the fiber.94
On January 31, 2008, the USPTO sent an Office Action
concerning the restricted claims.95 According to the USPTO, claims 14 and 6-14 were indefinite and claims 1-4, 6, 8-9, and 13-14 lacked
novelty pursuant to US Code Section 102.96 On April 21, 2008, the
applicants replied by amending claim 1, cancelling claims 4, 10, 12,
and 14, and rewriting claim 11 in independent form.97 On September
5, 2008, the USPTO sent a notice of allowance stating that the amended
application was acceptable,98 and on September 16, 2008, a patent was
issued.99
The applicants also filed a PCT application on August 19,
2005.100 The EPO conducted an international prior art search which
published on February 3, 2006.101 A year later, an international
preliminary report on patentability indicated claims 1-14 lacked
novelty and an inventive step.102 The last document available shows

91

U.S. Patent Application Serial No. 11/179,102 (filed July 15, 2005).
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, REQUIREMENT
FOR RESTRICTION/ELECTION (Dec. 14, 2007).
93
Id.
94
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102,
AMENDMENT/REQUEST FOR RECONSIDERATION AFTER NONFINAL REJECTION
(Jan. 18, 2008).
95
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, NONFINAL
REJECTION (Jan. 31, 2008).
96
Id.
97
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Apr. 21, 2008).
98
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, NOTICE OF
ALLOWANCE AND FEES DUE (Sept. 5, 2008).
99
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, ISSUE
NOTIFICATION (Sept. 16, 2008).
100
World Intellectual Property Organization (WIPO), Filler-Enhanced
Polymeric Fibers with Improved Mechanical Properties and Method for
Making, WO 2006/034697 (filed on Aug. 19, 2005).
101
European Patent Office (EPO), International Search Report, File No.
05791549.8 (Feb. 3, 2006).
102
Id.
92
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that in April 2007, the EPO sent a notice announcing the loss of rights
due to lack of payment.103
To summarize, the US application issued into a patent104 and
the EU application was abandoned.105 There were several differences
between the prosecution of the two applications. The first is that the
USPTO relied exclusively on US patent material,106 while the EPO
relied on a combination of US and foreign patent material.107 Notably,
shown in Table 1, none of the references relied on by the patent
offices overlapped. This had a big impact on the perceived validity of
the applications.

Table 1: References Cited by the USPTO108 and EPO109

For example, in the US, the examiner stated the fiber disclosed
in US-2005/0049355 possessed the same enhanced mechanical
properties as the fiber disclosed in nine of the applicant’s claims.110 In
103
European Patent Office (EPO), Application Deemed to be Withdrawn, File
No. 05791549.8 (Apr. 27, 2007).
104
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, ISSUE
NOTIFICATION (Sept. 16, 2008).
105
European Patent Office (EPO), Application Deemed to be Withdrawn, File
No. 05791549.8 (Apr. 27, 2007).
106
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, LIST OF
REFERENCES CITED BY APPLICANT AND CONSIDERED BY EXAMINER (Jan. 29,
2008); U.S. PATENT & TRADEMARK OFFICE, FILE NO. 11179102, LIST OF
REFERENCES CITED BY EXAMINER (Jan. 31, 2008).
107
European Patent Office (EPO), International Search Report, File No.
05791549.8 (Feb. 3, 2006).
108
LIST OF REFERENCES CITED BY APPLICANT, supra note 106; LIST OF
REFERENCES CITED BY EXAMINER, supra note 106.
109
International Search Report, supra note 107.
110
NONFINAL REJECTION, supra note 95.
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response, the applicant’s amended independent claim 1 to specify a
unique structural identity and composition, shown in Table 2.111
Claim 1: Amended
Filler-enhanced polymeric fiber comprising:
a polymer fiber: and
high aspect ratio filler particles dispersed within the polymeric fiber
and in intimate contact during processing with the polymeric fiber,
the filler particles, having an interfiber spacing of less than 350
nanometers, serving as templates to orient the molecular structure of
the polymer fiber to enhance fiber mechanical properties.112
Table 2: Amendments to Claim 1 of the US Application

In contrast, the EPO found that WO-03/020638 disclosed
essentially the same fiber disclosed in claim 1 of the application.113 The
EPO went on to indicate the remaining thirteen dependent claims did
not contain features that imparted novelty or an inventive step.114
Ultimately, the different references led the USPTO and EPO
to different conclusions about the applications. The EPO indicated
early in prosecution that every claim directed to the fiber either lacked
novelty or an inventive step, limiting the applicant’s path forward.115
Relying on a different set of references, the USPTO indicated some,
but not all, of the claims in the application were obvious, allowing the
applicants to cure their claims through amendment.116
B. Case 2: US 7,465,871 & EP 1,812,974
US Patent 7,465,871 started as a patent application filed on
October 29, 2004.117 The application consisted of 65 claims that were
directed towards a composite made of a semiconductor material
infused with nanoparticles.118 On December 2, 2005, the USPTO sent
a notice requiring applicants to restrict the invention to one of two
111

APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note

97.
112

Id.
European Patent Office (EPO), Copy of the International Preliminary
Report on Patentability, File No. 05800694.1 (Apr. 3, 2007).
114
Id.
115
Id.
116
APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note
97.
117
U.S. Patent No. 7,465,871 at [22] (filed Oct. 29, 2004).
118
U.S. Patent Application Serial No. 10/977,363 (filed Oct. 29, 2004).
113
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inventions enclosed in the patent.119 The USPTO stated that claims 156 were drawn to the composite material, while claims 57-65 were
drawn to a method of manufacturing the composite.120 On January 27,
2006, the applicants replied electing to restrict the invention to the
composite.121
On May 23, 2006, the USPTO sent an Office Action
concerning the remaining claims.122 The USPTO found that certain
claims were not novel, and a combination of references rendered
additional claims obvious.123 On September 22, 2006, the applicants
replied amending claims 1, 32, 38, 41, 53, 56, and adding a new
claim.124 On June 1, 2007, the USPTO sent a second Office Action
stating claims 1-11, 15-25, 27-31, 38-43, 52, 53, 56, and 66 were not
novel in light of new prior art.125 On October 10, 2007, the applicants
replied with a declaration that one of the references was authored by
the co-inventors,126 prompting the USPTO to withdraw their rejection
of claims 15-16, 22, 24-25, 27-28, 52-53, and 66.127
On April 8, 2008, the applicants amended claim 1, canceled
claims 38-43 and 56, and added claims 70-160.128 On June 18, 2008,
the USPTO withdrew their rejection of claim 1 but rejected claims 106109, 128-131, 139-142, and 150-153.129 On July 3, 2008, the applicants
replied cancelling the rejected claims.130 On October 10, 2008, the

119
U.S. PATENT & TRADEMARK OFFICE, FILE
FOR RESTRICTION/ELECTION (Dec. 2, 2005).
120
121

Id.
U.S.

NO. 10977363, REQUIREMENT

PATENT & TRADEMARK OFFICE, FILE NO. 10977363,
AMENDMENT/REQUEST FOR RECONSIDERATION AFTER NONFINAL REJECTION
(Jan. 27, 2006).
122
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, NONFINAL
REJECTION (May 23, 2006).
123
Id.
124
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Sept. 22, 2006).
125
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, NONFINAL
REJECTION (June 1, 2007).
126
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Oct. 10, 2007).
127
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, FINAL
REJECTION (Dec. 27, 2007).
128
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Apr. 8, 2008).
129
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, NONFINAL
REJECTION (June 18, 2008).
130
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (July 3, 2008).
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USPTO sent a notice of allowance and on December 16, 2008 a patent
was issued.131
The applicants also filed a PCT application on October 31,
2005.132 The EPO conducted an international prior art search which
published on May 16, 2007.133 An IPR followed on February 12, 2008,
indicating the claims defined three different inventions and that claims
1-15, 20-30, and 37-41 were not novel.134 On June 24, 2009, the
applicants replied electing to restrict the application to one of the
inventions, and amended claim 1.135 On February 14, 2014, the EPO
sent a notice that the application still was not in conformity with the
EPC.136 On June 16, 2014, the applicants replied with a second
amendment to claim 1 and canceled another claim.137 Satisfied with the
applicant’s amendments, the EPO issued a patent on July 16, 2015.138
To summarize, both applications issued into patents.139 The
USPTO relied on a combination of US patent material and non-patent
references,140 whereas the EPO relied on US and foreign patent
material and non-patent references.141 Notably, three of the references
131

U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, ISSUE
NOTIFICATION (Dec. 16, 2008).
132
World Intellectual Property Organization (WIPO), Nanocomposites with
High Termoelectric Figures of Merit, WO 2006/127923 (filed on Oct. 31,
2005).
133
European Patent Office (EPO), Copy of the International Search Report,
File No. 05858279.2 (May 16, 2007).
134
European Patent Office (EPO), Copy of the International Preliminary
Report on Patentability, File No. 05858279.2 (Feb. 12, 2008).
135
European Patent Office (EPO), Reply to Communication from the
Examining Division, File No. 05858279.2 (June 24, 2009).
136
European Patent Office (EPO), Communication from the Examining
Division, File No. 05858279.2 (Feb. 14, 2014).
137
European Patent Office (EPO), Reply to Communication from the
Examining Division, File No. 05858279.2 (June 16, 2014).
138
European Patent Office (EPO), Communication About Intention to Grant a
European Patent, File No. 05858279.2 (Nov. 4, 2014).
139
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, ISSUE
NOTIFICATION (Dec. 16, 2008); European Patent Office (EPO),
Communication About Intention to Grant a European Patent, File No.
05858279.2 (Nov. 4, 2014).
140
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 10977363, LIST OF
REFERENCES CITED BY EXAMINER (May 23, 2006); U.S. PATENT &
TRADEMARK OFFICE, FILE NO. 10977363, LIST OF REFERENCES CITED BY
EXAMINER (June 1, 2007); U.S. PATENT & TRADEMARK OFFICE, FILE NO.
10977363, LIST OF REFERENCES CITED BY EXAMINER (Dec. 27, 2007).
141
European Patent Office (EPO), Copy of the International Search Report,
File No. 05858279.2 (May 16, 2007).
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relied on by the patent offices overlapped, shown in Table 3. This led
the applicants to pursue similar prosecution strategies in both
jurisdictions.

Table 3: References Cited by the USPTO142 and EPO143

For example, both patent offices rejected independent claim 1
in view of US-2003/0099279.144 In response, the applicants amended
claim 1 by adding that the nano particles were dispersed randomly
relative to one another,145 as indicated in Table 4.

142

LIST OF REFERENCES CITED BY EXAMINER (May 23, 2006), supra note 140;
LIST OF REFERENCES CITED BY EXAMINER (June 1, 2007), supra note 140;
LIST OF REFERENCES CITED BY EXAMINER (Dec. 27, 2007), supra note 140.
143
Copy of the International Search Report, supra note 141.
144
NONFINAL REJECTION, supra note 122; European Patent Office (EPO),
Communication from the Examining Division, File No. 05858279.2 (Feb. 13,
2009).
145
APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note
124; Reply to Communication from the Examining Division, supra note 135.
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US Claim 1: Amended

EU Claim 1: Amended

A thermoelectric
nanocomposite semiconductor
composition, comprising: a
semiconductor host material,
and a plurality of nano-sized
inclusions distributed randomly
within said host material, said
inclusions being formed of a
semiconductor inclusion
material, wherein said host
material comprises dopants,
and wherein the conduction
band-edge offset or a valence
band-edge offset between said
host material and the inclusion
material at an interface of the
two materials is less than about
5kT,wherein k is the Boltzman
constant and T is an average
temperature of said nano
composite composition.146

A thermoelectric
nanocomposite semiconductor
composition, comprising: a
semiconductor host material,
and a plurality of nano-sized
inclusions distributed randomly
within said host material, said
inclusions being formed of a
semiconductor inclusion
material, wherein the host
material comprises a plurality
of nano-sized structures formed
of a semiconductor material
different than said
semiconductor inclusion
material, and wherein the
conduction bad-edge offset or a
valence band-edge offset
between said host material and
the inclusion material at an
interface of the two materials is
less than about 5kbT, where kb
is the Boltzman constant and T
is an average temperature of
said nanocomposite
composition.147

Table 4: Amendments Made to the US and EU Applications

The additional amendments in the EU application were
prompted by US-2003/0099279 and two non-patent references unique
to the EU prosecution.148 For example, the EPO stated the references
taught a composite where the nanoparticles were made from the same
material.149 To overcome this, the applicants amended claim 1 to
specify the host material and nanoparticles were made from different
146
APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note
124; APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT supra note
128.
147
Reply to Communication from the Examining Division, supra note 135;
Reply to Communication from the Examining Division, supra note 137.
148
Id.
149
Id.
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materials,150 shown in Table 4. In contrast, the applicants in the US
combined the limitation from claim 15 with claim 1, after the USPTO
indicated claim 1 shared the same materials and properties with another
US patent reference.151
Ultimately, the outcomes of the applications were similar in
both jurisdictions. Both patents issued and similar prior art sets allowed
the applicants to make similar amendments in some respects. However,
the US patent contains broader claims than the EU patent because the
non-patent references cited by the EPO required the applicants to make
additional amendments to the EU application.
C. Case 3: US 2012/0208002 & EP 2,470,472
On August 25, 2010, the applicants filed a PCT application
directed to a ceramic composite material consisting of aligned
nanotubes that improved thermal conductivity.152 The EPO conducted
an international prior art search which published on November 10,
2010.153 An IPR followed on February 28, 2012, and stated that each
claim lacked an inventive step.154 On March 19, 2012, the applicants
amended claim 9 and 14 and canceled claims 19-22.155 On June 23,
2016, the EPO sent a notice that the application did not meet the
patentability requirements of the EPC for the reasons stated in the
IPR.156 On November 3, 2016, the applicants replied that the claims did
not lack inventive step for the reasons summarized in Table 5.

150

Id.
APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT, supra note
128.
152
World Intellectual Property Organization (WIPO), Composite Materials
Containing Aligned Nanotubes and the Production Thereof, WO 2011/024000
(filed on Aug. 25, 2010).
153
European Patent Office (EPO), International Search Report, File No.
10752912.5 (Nov. 10, 2010).
154
European Patent Office (EPO), International Preliminary Report on
Patentability, File No. 10752912.5 (Feb. 28, 2012).
155
European Patent Office (EPO), Amended Claims with Annotations, File No.
10752912.5 (Mar. 19, 2012).
156
European Patent Office (EPO), Communication from the Examining
Division, File No. 10752912.5 (June 23, 2016).
151
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Inventive Step Argument
The thermal conductivity of
the material claimed in the
invention was significantly
higher than that of the
material specified in the prior
art157
The references were not an
appropriate starting point for
assessing inventive step
because the references were
not concerned with the same
technical problem as the
invention159
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EPO Response
The use of aligned nanotubes
was in reach of the skilled
person in light of the prior
art158
The subject matter of claims
1-10 could be considered new
and inventive but some
additional objections needed
to be overcome160

Table 5: Applicant’s Inventive Steps Arguments and the EPO Response

Among the additional objections that need to be overcome
were that claim 1 was overly broad.161 The applicant’s narrowed claim
1, and the EPO subsequently granted the patent on May 3, 2020.162
The applicants also submitted a US patent application on May 7,
2012.163 The USPTO required the application to be restricted to one
invention because claims 1-9 and 11-13 were drawn to a method of
forming the ceramic composite while claims 14-21 were drawn to the
ceramic composite itself.164 On April 25, 2013, the applicants replied
electing to restrict the invention to the method of forming the ceramic

157

European Patent Office (EPO), Reply to Communication from the
Examining Division, File No. 10752912.5 (Nov. 3, 2016).
158
European Patent Office (EPO), Communication from the Examining
Division, File No. 10752912.5 (May 10, 2017).
159
European Patent Office (EPO), Amended Claims with Annotations, File No.
10752912.5 (Feb. 15, 2018).
160
European Patent Office (EPO), Result of Consultation by Telephone/in
Person, File No. 10752912.5 (Feb. 28, 2018).
161
Id.
162
European Patent Office (EPO), Decision to Grant a European Patent, File
No. 10752912.5 (May 3, 2020).
163
U.S. Patent Application Serial No. 13/392,124 (filed May 7, 2012).
164
Id.
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composite.165 On August 6, 2013, the USPTO sent its first Office
Action stating that claims 1-5, 7-9, and 11-13 were obvious in light of
two of the prior art references.166 The applicants responded arguing the
invention was nonobvious, shown in Table 6.
Nonobvious Argument
Fibers disclosed in the prior art
were much larger than the
nanotubes disclosed in the
invention167
The invention taught dipping an
array of nanotubes in a solution
whereas one reference taught
pouring a ceramic solution on
an array169

PTO Response
The fibers in the references
could be smaller than those
argued by applicant168
Applicants attacked references
individually when the rejection
was based on obviousness170

Table 6: Applicant’s Nonobviousness Arguments and the USPTO Response

Both arguments were rejected by the USPTO, prompting the
applicants to submit amendments to claim 1.171 On March 1, 2016, the
PTO sent their final Office Action stating claim 1 was obvious in light
of new prior art.172 The next and last available document shows that in
October 2016, the USPTO sent a notice to the applicants that they
failed to reply to the Office Action.173
To summarize, the EU application issued into a patent174
whereas the US application was abandoned.175 The USPTO relied on
165

U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, RESPONSE TO
ELECTION/RESTRICTION FILED (Apr. 25, 2013).
166
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, NONFINAL
REJECTION (Aug. 6, 2013).
167
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124,
AMENDMENT/REQUEST FOR RECONSIDERATION AFTER NONFINAL REJECTION
(Dec. 5, 2013).
168
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, FINAL
REJECTION (Dec. 23, 2013).
169
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Dec. 23, 2013).
170
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, NONFINAL
REJECTION (Oct. 9, 2014).
171
FINAL REJECTION, supra note 168; NONFINAL REJECTION, supra note 170.
172
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, FINAL
REJECTION (Mar. 1, 2016).
173
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, ABANDONMENT
(Oct. 25, 2016).
174
Decision to Grant a European Patent, supra note 162.
175
ABANDONMENT, supra note 173.
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three US patents, three US patent applications, one foreign patent, and
four non-patent references.176 The EPO relied on one international
patent application and four non-patent references.177 None of the
references relied on by the patent offices overlapped, as indicate in
Table 8. Again, this had a big impact on the perceived validity of the
applications.

Table 8: References Cited by the USPTO178 and EPO179

For example, both applicants amended claim 1 to specify the
array of substantially aligned nanotubes were carbon nanotubes,180 as
shown in Table 9. Additionally, both applicants amended claim 1 to
specify that the ceramic matrix material is in the form of a sol.181

176

U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, LIST OF
REFERENCES CITED BY EXAMINER (Aug. 6, 2013); U.S. PATENT &
TRADEMARK OFFICE, FILE NO. 13392124, LIST OF REFERENCES CITED BY
EXAMINER (Feb. 27, 2015); U.S. PATENT & TRADEMARK OFFICE, FILE NO.
13392124, LIST OF REFERENCES CITED BY EXAMINER (Mar. 1, 2016).
177
European Patent Office (EPO), International Search Report, File No.
10752912.5 (Aug. 8, 2013).
178
LIST OF REFERENCES CITED BY EXAMINER (Aug. 6, 2013), supra note 176;
LIST OF REFERENCES CITED BY EXAMINER (Feb. 27, 2015), supra note 176;
LIST OF REFERENCES CITED BY EXAMINER (Mar. 1, 2016), supra note 176.
179
International Search Report, supra note 177.
180
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Feb. 9, 2015); European
Patent Office (EPO), Reply to Communication from the Examining Division,
File No. 10752912.5 (Sept. 19, 2019).
181
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Jan. 22, 2016); Reply to
Communication from the Examining Division, supra note 180.
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EU Claim 1: Amended

US Claim 1: Amended

A method of forming a
composite material comprising
nanotube oriented in a matrix
comprising a ceramic material,
the method comprising the
steps of: providing an array of
substantially aligned
nanotubes, wherein the
nanotubes comprise carbon
nanotubes; providing a
ceramic matrix material in the
form of a solution; applying
the solution to the nanotubes;
allowing the solution to
infiltrate into the array of
nanotubes; and sintering the
ceramic matrix material to
form the composite material;
wherein the nanotubes are
substantially aligned in the
ceramic matrix, wherein the
ceramic matrix is formed by a
sol-gel process.182

A method of forming a composite
material comprising nanotube
oriented in a matrix comprising a
ceramic material, the method
comprising the steps of: providing
an array of substantially aligned
nanotubes, wherein the nanotubes
are carbon nanotubes; providing a
ceramic matrix material in the form
of a solution; applying the solution
to the nanotubes; allowing the
solution to infiltrate into the array of
nanotubes; and sintering the
ceramic matrix material to form the
composite material; wherein the
nanotubes are substantially aligned
in the ceramic matrix, wherein the
step of applying the solution to the
nanotubes comprises dipping the
array of nanotubes in the solution
and the solution infiltrates into the
array of nanotubes by capillary
action; wherein the solution of the
ceramic matrix material is provided
in the form of a sol, and wherein the
sol is a colloidal suspension having
a particle size of 1 to 10 nm.183

Table 9: Amendments Made to the US and EU Applications

However, the additional US patent material and non-patent
references relied on by the USPTO rendered the applicant’s claims
obvious in the eyes of the examiner.184 The US applicants did not argue
the prior art was not analogous to the invention, which was a successful
argument at the EPO.185 Rather, the US applicants made new
182
APPLICANT ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Feb. 9,
2015), supra note 180; APPLICANT ARGUMENTS/REMARKS MADE IN AN
AMENDMENT (Jan. 22, 2016), supra note 181.
183
Reply to Communication from the Examining Division, supra note 180.
184
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, FINAL
REJECTION (Mar. 1, 2016).
185
Amended Claims with Annotations, supra note 159.
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arguments and amendments without countering the points made by the
examiner—a strategy that was ineffective.186
Ultimately, the applicants made similar amendments during
prosecution, but the different prior art relied on by the patent offices
and nonobvious arguments made by the applicants resulted in different
outcomes for the applications. In this case, the patent and non-patent
references relied on by the USPTO prevented the US applicants from
successfully amending their claims, as the applicants did in the EU.
D. Case 4: US 6,346,189 & WO 00/09443
US Patent 6,346,189 was one of the “building block” patents187
and described “Carbon Nanotube Structures Made Using Catalyst
Islands.”188 The US patent issued before the USPTO began publishing
prosecution history, so it was not possible to compare the US
prosecution with the EU prosecution. However, the European
prosecution history was published and revealed the application was
abandoned.189 Previous scholars would suggest the EPO’s investment
in getting patent quality right at early stages of prosecution gave the
applicant a good indication of the likely outcome of their application.190
In this case, the international prior art search found a US patent and
two international patent applications, listed in Table 10, that were
relevant to every claim in the patent.191

Table 10: References Cited by the EPO192

186
U.S. PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (July 27, 2015); U.S.
PATENT & TRADEMARK OFFICE, FILE NO. 13392124, APPLICANT
ARGUMENTS/REMARKS MADE IN AN AMENDMENT (Jan. 22, 2016).
187
Lemley, supra note 15, at 613.
188
U.S. Patent No. 6,346,189.
189
European Patent Office (EPO), Matter Concerning the Application, File
No. 99932269.6 (Sept. 17, 2001).
190
See Chien, supra note 12, at 107.
191
European Patent Office (EPO), Copy of the International Search Report,
File No. 99932269.2 (Oct. 21, 1999).
192
Id.
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Notably, each of references in the international prior art search
are also cited as references in the US patent.193 Without analyzing the
US prosecution, it is not clear whether the references affected the
outcome of the prosecution. It is possible the references were included
in the US patent without affecting the scope of the claims, like in the
previous nanotechnology patent study.194
CONCLUSION
The results from the three case studies largely confirm the
prediction that US nano patent applications would issue into patents at
a higher rate than the European Applications. In one study, the EPO
relied on different prior art references than the USPTO and indicated
to the applicants early that every claim in the application lacked novelty
and an inventive step.195 Also as predicted, the EU patents contained
narrower claims.196 While the patent offices relied on several common
references, the unique references found by the EPO forced additional
amendments in the EU applications.197 This could be explained by the
EPO’s reputation as a better patent office.198 It follows that if the EPO
applies more examiners and time to each application, one result would
be higher quality prior art references. With this in mind,
nanotechnology companies should be prepared for different treatment
at the EPO than at the USPTO, and, where applications issue into
patents, different patent scopes.

193

’189 Patent at [56].
Escoffier, supra note 45, at 29.
195
See discussion supra Section IV.A.
196
See supra Table 4.
197
See Reply to Communication from the Examining Division, supra note 137.
198
Chien, supra note 12, at 74.
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